Skip to main content
STCUBE logo

STCUBE — Investor Relations & Filings

Ticker · 052020 ISIN · KR7052020005 KO Professional, scientific and technical activities
Open in API
Filings indexed 269 across all filing types
Latest filing 2024-12-03 Director's Dealing
Country KR South Korea
Listing KO 052020

About STCUBE

https://www.stcube.com/en/

STCube is a biopharmaceutical company specializing in the research and development of innovative immuno-oncology therapies. The company focuses on discovering treatments that target novel immune checkpoints to overcome cancer's immune evasion mechanisms. Its primary area of research involves BTN1A1, a novel immune checkpoint target often expressed in a mutually exclusive manner with PD-L1. STCube's lead drug candidate, Nelmastobart, is a first-in-class anti-BTN1A1 immune checkpoint inhibitor. This therapy is being developed to provide a new treatment option for patients with treatment-resistant, refractory, or recurrent cancers that have limited therapeutic alternatives. The company utilizes a precision-medicine, biomarker-driven approach in its clinical development programs.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Stephen Sunghan Yoo) of STCube. This type of filing, which details personal share transactions and changes in ownership by company insiders, is classified as 'Director's Dealing' (DIRS) in the provided taxonomy.
2024-12-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when an insider or major shareholder changes their stake in a company. This corresponds to the 'Director's Dealing' category, which covers insider transactions and changes in ownership by company directors and major shareholders.
2024-12-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This is a standard regulatory filing used to disclose insider transactions (purchases/sales of shares by directors or major shareholders). Based on the provided categories, this falls under 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2024-12-03 Korean
증권발행결과(자율공시) (주주우선공모증자)
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '증권 발행결과' (Securities Issuance Results) regarding a capital increase through a shareholder-priority public offering. It details the number of shares issued, the total amount raised, and the payment completion date. This falls under the category of share issuance and capital changes.
2024-11-29 Korean
증권발행실적보고서
Share Issue/Capital Change Classification · 1% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed by STCube. This document is a mandatory regulatory filing in South Korea (DART system) that details the final results of a capital raise (in this case, a rights offering/share issuance), including the number of shares issued, the amount raised, the allocation status, and the intended use of proceeds. It is not an announcement of a report (RPA) but the actual report of the issuance results itself. Therefore, it falls under the category of Regulatory Filings (RNS) as it is a specific statutory filing that does not fit into the other specialized categories like 10-K or ER.
2024-11-29 Korean
유상증자또는주식관련사채등의청약결과(자율공시)
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement regarding the results of a paid-in capital increase (rights offering/public offering) for STCube. It details the subscription results, including the number of shares subscribed, subscription rates, and future schedules for payment and listing. This falls under the category of share issuance and capital changes.
2024-11-28 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.